Publications by authors named "Ibrahim M Abd El-Salam"

The development of new anticancer agents with a selective action mechanism has become a significant scientific challenge, especially as cancers remain the world's leading cause of death. Actinobacteria and its bioactive compounds have recently become a promising perspective alternative to cancer therapy. In this study, some extracted metabolites of Micromonospora exhibited potent antimicrobial with microbial inhibition zone ≥ 7 mm, and cytotoxic activities against MCF-7 and HepG2 cell lines with promising activities ≥ 85%.

View Article and Find Full Text PDF

Background: Hepatocellular carcinoma is triggered by many factors including infection with hepatitis C virus. The molecular basis, however, of the development of HCV-related HCC remains unknown.

Objective: This work was designated to compare the circulating levels of some molecular markers between HCV-infected and HCV-free HCC patients.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Ibrahim M Abd El-Salam"

  • - Ibrahim M Abd El-Salam's research primarily focuses on the discovery of novel therapeutic agents derived from natural sources, specifically through the study of Actinobacteria such as Micromonospora, highlighting their potential in cancer treatment due to significant antimicrobial and cytotoxic activities.
  • - A notable study conducted by Abd El-Salam demonstrates that extract metabolites from Micromonospora have shown effective microbial inhibition and considerable cytotoxic effects against breast (MCF-7) and liver (HepG2) cancer cell lines, indicating their promise in anticancer drug development.
  • - In addition to his work on natural products, Abd El-Salam has investigated the molecular underpinnings of hepatitis C virus-related hepatocellular carcinoma, aiming to delineate the differences in molecular marker levels between infected and non-infected patients, thereby enhancing understanding of HCV's role in liver cancer progression.